eNauka - pregled
Pregled prema Autor Stanic, Nemanja
Prikaz rezultata 1 do 4 od 4
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2025 | Evaluating the Predictive Value of Clinical Factors for Pembrolizumab Efficacy and Safety in Advanced NSCLC with High PD-L1 Expression (TPS ≥ 50%) | Djordjevic, Fedja; Ljujic, Katarina; Stanic, Nemanja; Nikolic, Neda; Markovic, Ivan; Spasic, Jelena | Naučni članak | 21M21 - Vodeći međunarodni časopis kategorije M21 |
| 2015 | P-279 Cetuximab as third line treatment of metastatic colorectal carcinoma (mCRC) – 5-year experience from the Institute of Oncology and Radiology of Serbia | Spasic, Jelena   ; Stanic, Nemanja; Ristic, Marija; Djordjevic, Feđa; Nikolic, Neda ; Nikolić, Vladimir ; Pupovac, S.; Radosavljević, Davorin | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2015 | P-329 Reintroduction of oxaliplatin for patients with metastatic colorectal cancer | Ristic, Marija; Stanic, Nemanja; Ristic, Dušan; Nikolić, Vladimir ; Spasic, Jelena ; Radosavljević, Davorin | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2015 | PO58 DOES PREVIOUS NEOADJUVANT/ADJUVANT TRASTUZUMAB INFLUENCE THE DISEASE OUTCOME OF METASTATIC HER2 POSITIVE BREAST CANCER PATIENTS TREATED WITH FIRST LINE TRASTUZUMAB AND CHEMOTHERAPY | Milosevic, Snezana; Stanic, Nemanja; Bozovic-Spasojevic, Ivana; Tomašević, Zorica ; Šušnjar, Snežana | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |